MIRA
MIRA Pharmaceuticals, Inc.
There isn't enough reported data to score MIRA yet.
MIRA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
MIRA's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
MIRA PE Valuation
MIRA has no meaningful PE right now: it lost money over the past year.
MIRA Forward outlook
There aren't enough analyst estimates for MIRA to show an outlook.
MIRA Earnings Per Share
MIRA lost $0.48 per share over the past year, a bigger loss than the year before.
MIRA Quarterly Revenue
MIRA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.2M | -$405.9K |
| Q1 2026 | -$1.2M | +$428.7K |
| Q4 2025 | -$1.1M | +$670K |
| Q3 2025 | -$1.1M | +$745.2K |
| Q2 2025 | -$799.7K | +$64.3K |
| Q1 2025 | -$1.6M | -$580.5K |
| Q4 2024 | -$1.8M | -$770K |
| Q3 2024 | -$1.8M | -$80.8K |
MIRA has burned cash in almost every quarter: −$5M over the past year, against −$6M the year before.
MIRA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +80.7K shares |
| 1 year | +152% | +25.4M shares |
| 3 years | +185% | +27.3M shares |
MIRA has 42M diluted shares, up 152% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q1 2021 | — |
MIRA Net Leverage
MIRA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MIRA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.9 | Neutral |
| Stochastic | 13.4 | Oversold |
MIRA's weekly RSI is 39 (neutral) and its Stochastic is 13 (oversold).
MIRA PE vs Healthcare Sector
MIRA has no meaningful PE right now: it lost money over the past year.
MIRA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.67 | 3% below |
| 20 week MA | $0.77 | 16% below |
| 50 week MA | $1.02 | 36% below |
| 100 week MA | $1.15 | 43% below |
MIRA is in a downtrend: it's below all four of its weekly moving averages, and 43% below its 100-week average.
MIRA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $6.26 | $1.05 | -83% |
| 2024 | $1.05 | $1.18 | +12% |
| 2025 | $1.18 | $1.51 | +28% |
| 2026 YTD | $1.51 | $0.65 | -57% |
MIRA is down 57% so far in 2026, after finishing higher in two of the previous three years.